events

AI-ML in Drug Discovery Summit

ONLINE

The AI-ML: Drug Discovery Summit – the industry’s leading R&D AI event – returns in 2021, with brand-new case studies, cutting-edge discussions, industry-shaping debates to help you overcome your data quality, standardization, and sharing challenges.

January 26, 2021 to January 28, 2021

organizations

Recursion Pharmaceuticals

COMPANY

USA

Recursion Pharmaceuticals is reengineering drug discovery by taking a target-agnostic approach that combines automation, machine learning and the world’s largest biological image dataset with a highly cross-functional team to discover transformative new treatments.

organizations

ReviveMed

COMPANY

USA

ReviveMed is a precision-medicine platform that leverages the data from small molecules or metabolites.

organizations

Oriel Research Therapeutics

COMPANY

USA

Data-driven diagnostics and therapy matching using genomics and state-of-the-art ML based models

organizations

Nuritas

COMPANY

Dublin

Nuritas combines artificial intelligence and genomics to discover and unlock natural bioactive peptides with extraordinary health benefits

organizations

Invivo AI

COMPANY

Canada

InVivo AI is using artificial intelligence to streamline the development of new medications

organizations

InterVenn Biosciences

COMPANY

USA

InterVenn Biosciences combines AI/ML, glycoproteomics & LC-MS for biomarker and target discovery.

organizations

Iktos

COMPANY

France

Artificial Intelligence for new drug design